Factors that may affect the response of onychomycosis to oral antifungal therapy.
With the advent of the newer oral antifungals available to treat onychomycosis, the majority of patients respond to therapy. However, there may be subsets of patients who exhibit poor response or failure. Possible explanations for this may be grouped into categories, including: (i) patient characteristics; (ii) organisms causing or associated with the nail infection; (iii) nail characteristics; and (iv) local diseases involving the nail.
Gupta
A K
AK
Department of Medicine, Sunnybrook Health Science Center, Toronto, Canada. agupta@execulink.com
Daniel
C R
CR
D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008297:Male; D009262:Nails / Q000382:microbiology / Q000473:pathology; D014009:Onychomycosis / Q000188:drug therapy*; D010349:Patient Compliance
D000935:Antifungal Agents